Dolby Laboratories Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Dolby Laboratories stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DLB, but not buy additional shares or sell existing shares.
View analyst ratings for Dolby Laboratories or view top-rated stocks.

Wall Street analysts have given Dolby Laboratories a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Dolby Laboratories wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Dolby Laboratories is scheduled to release its next quarterly earnings announcement on Monday, August 2nd 2021.
View our earnings forecast for Dolby Laboratories.

Dolby Laboratories, Inc. (NYSE:DLB) posted its quarterly earnings data on Tuesday, May, 4th. The electronics maker reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.47 by $0.44. The electronics maker had revenue of $319.56 million for the quarter, compared to the consensus estimate of $294.29 million. Dolby Laboratories had a trailing twelve-month return on equity of 9.89% and a net margin of 19.91%. The firm's revenue was down 9.2% compared to the same quarter last year. During the same quarter last year, the firm earned $1.04 earnings per share.
View Dolby Laboratories' earnings history.

Dolby Laboratories' stock was trading at $60.23 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DLB shares have increased by 58.4% and is now trading at $95.43.
View which stocks have been most impacted by COVID-19.

Dolby Laboratories declared a quarterly dividend on Tuesday, May 4th. Stockholders of record on Monday, May 17th will be given a dividend of $0.22 per share on Tuesday, May 25th. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.92%. The ex-dividend date is Friday, May 14th.
View Dolby Laboratories' dividend history.

Dolby Laboratories pays an annual dividend of $0.88 per share and currently has a dividend yield of 0.94%. Dolby Laboratories does not yet have a strock track record of dividend growth. The dividend payout ratio of Dolby Laboratories is 38.26%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Dolby Laboratories will have a dividend payout ratio of 30.34% next year. This indicates that Dolby Laboratories will be able to sustain or increase its dividend.
View Dolby Laboratories' dividend history.

Dolby Laboratories issued an update on its third quarter 2021 earnings guidance on Tuesday, May, 11th. The company provided EPS guidance of 0.370-0.520 for the period, compared to the Thomson Reuters consensus estimate of $0.630. The company issued revenue guidance of $260 million-$290 million, compared to the consensus revenue estimate of $278.80 million.

3 brokers have issued twelve-month price objectives for Dolby Laboratories' shares. Their forecasts range from $83.00 to $89.00. On average, they anticipate Dolby Laboratories' share price to reach $86.00 in the next twelve months. This suggests that the stock has a possible downside of 9.9%.
View analysts' price targets for Dolby Laboratories or view top-rated stocks among Wall Street analysts.

253 employees have rated Dolby Laboratories CEO Kevin J. Yeaman on Glassdoor.com. Kevin J. Yeaman has an approval rating of 84% among Dolby Laboratories' employees.

Some companies that are related to Dolby Laboratories include Amphenol (APH), Corning (GLW), Littelfuse (LFUS), Rogers (ROG) and Vishay Intertechnology (VSH).
View all of DLB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include InterDigital (IDCC), Energy Transfer (ET), Advanced Micro Devices (AMD), AbbVie (ABBV), Abbott Laboratories (ABT), Bank of Hawaii (BOH), Mastercard (MA), STAG Industrial (STAG), Comcast (CMCSA) and NVIDIA (NVDA).

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.81%), Clearbridge Investments LLC (3.51%), Jackson Square Partners LLC (2.73%), Soma Equity Partners LP (2.26%), Bank of New York Mellon Corp (0.94%) and Geode Capital Management LLC (0.86%). Company insiders that own Dolby Laboratories stock include Avadis Tevanian, Dagmar Dolby, Ed H Bowman Jr, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay and Todd Pendleton.
View institutional ownership trends for Dolby Laboratories.

DLB stock was sold by a variety of institutional investors in the last quarter, including Ceredex Value Advisors LLC, Alliancebernstein L.P., Trinity Street Asset Management LLP, Renaissance Technologies LLC, Trigran Investments Inc., Marathon Asset Management LLP, Bank of New York Mellon Corp, and Bank of Montreal Can. Company insiders that have sold Dolby Laboratories company stock in the last year include Avadis Tevanian, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay, and Todd Pendleton.
View insider buying and selling activity for Dolby Laboratories or view top insider-selling stocks.

DLB stock was acquired by a variety of institutional investors in the last quarter, including Jackson Square Partners LLC, Standard Life Aberdeen plc, BlackRock Inc., BNP Paribas Arbitrage SA, Sei Investments Co., Soma Equity Partners LP, Acadian Asset Management LLC, and Bank of Nova Scotia.
View insider buying and selling activity for Dolby Laboratories or or view top insider-buying stocks.

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DLB stock can currently be purchased for approximately $95.43.

Dolby Laboratories has a market capitalization of $9.70 billion and generates $1.16 billion in revenue each year. The electronics maker earns $231.36 million in net income (profit) each year or $2.30 on an earnings per share basis.

Dolby Laboratories employs 2,289 workers across the globe.

The following companies are subsidiares of Dolby Laboratories: Coding Technologies, Dolby International AB, Dolby Laboratories Licensing Corporation, Doremi Labs, Step Labs, and Voxeet.

Dolby Laboratories was founded in 1965.

The official website for Dolby Laboratories is www.dolby.com.

Dolby Laboratories is headquartered at 1275 MARKET STREET, SAN FRANCISCO CA, 94103.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at (415) 558-0200 or via email at [email protected]